Damiaan Denys is an expert in Psychiatry at Amsterdam University Medical Center (Netherlands). As of October 2026, ScienceLeadR ranks Damiaan Denys in the top 1% of experts worldwide for Obsessive-Compulsive Disorder, Anxiety Disorders and Electric Stimulation Therapy. Damiaan Denys has authored 518 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 1,761 (community average: 125). How the SLR is computed.

LeadR Profile

Damiaan Denys Amsterdam University Medical Center Netherlands
1 761 ScienceLeadR Reputation 1761
Network Map

Psychiatry

Subspecialties: Neurology - Psychology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Amsterdam University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 518

Citations

Citations: 27 100 1st author: 31 Last author: 212 Unique author: 11


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
No Cognitive Scarring Over 20 Years in Recurrent Depression: Bidirectionality of Cognitive Functioning and Depression.
PMID 42787777 — depression, cognitive dysfunction, cognition disorders, memory, depressive disorder, major
Clin Psychol Eur20260
Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.
PMID 42343090 — genes, biological science disciplines, brain, phenotype, obsessive-compulsive disorder, gene expression
Nat Commun20261
Influence of Age and Gender on Short-Term Efficacy, Acceptability and Safety of Antipsychotic Drug Treatment of Adolescents With Schizophrenia: An Individual Patient Data Meta-Analysis.
PMID 42155624 — safety, incidence, pharmaceutical preparations, weight gain, drug-related side effects and adverse reactions, adolescent, schizophrenia, antipsychotic agents, therapeutics
J Am Acad Child Adolesc Psychiatry20260
Barriers and facilitators to implementing deep brain stimulation for psychiatric disorders: a systematic review.
PMID 42120357 — mental disorders, brain, deep brain stimulation, therapeutics, psychiatry
Transl Psychiatry20260
Neural variability across the transition to motherhood: Enhanced moment-to-moment neural variability during mentalizing in first-time mothers.
PMID 42062236 — pregnancy, parenting, mothers, theory of mind, neurosecretory systems, hormones, social cognition, nervous system, parity, postpartum period, mentalization, child
J Neuroendocrinol20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 2
Phase 3 1

By status:

Active not recruiting 1
Completed 1
Recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Imagery Rescripting as a Treatment for Early Psychosis
NCT06539780 — imagery, psychotherapy, emotions, neurocognitive disorders, signs and symptoms, schizophrenia, therapeutics, wounds and injuries, psychotic disorders
N/AActive not recruiting2024
Imagery Rescripting as a Stand alone Treatment for OCD and BDD
NCT06346301 — compulsive personality disorder, imagery, psychotherapy, personality disorders, personality, emotions, aftercare, signs and symptoms, body dysmorphic disorders, anxiety disorders, therapeutics, obsessive-compulsive disorder
N/ARecruiting2023

LeadR Networks

Main global connection map